Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting
Clinical trial NCT04085393 · WITHDRAWN
Trial details
- NCT number
- NCT04085393
- Sponsor
- University of Alabama at Birmingham
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-15
- Primary completion
- 2020-08-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.